Reference

Peptide Research Glossary

Plain-language definitions of the analytical, chemical, pharmacological, and sourcing vocabulary used in peptide research. Terms cover HPLC methodology, Certificate of Analysis standards, reconstitution procedures, the GH axis, and individual research compounds.

For laboratory research use only. All compounds and procedures referenced are for in-vitro and animal research — not for human consumption or therapeutic application.

A

Acetic Acid (in peptide reconstitution)#: Dilute acetic acid (typically 0.1–1%) is used as an alternative diluent or co-solvent for peptides that are poorly soluble in neutral aqueous solutions, such as those with a high proportion of hydrophobic or positively charged residues. The mild acid environment protonates basic side chains and reduces intermolecular electrostatic attraction, increasing peptide solubility. When acetic acid is used for initial reconstitution, the solution may then be diluted with bacteriostatic water to the desired final concentration.
Aggregation#: The non-covalent or covalent clustering of individual peptide molecules into larger assemblies, often resulting in loss of the compound's dissolved, monomeric form and potentially its biological activity. Peptide aggregation can be triggered by excessive agitation, temperature fluctuations, high concentration, freeze-thaw cycling, or pH changes during or after reconstitution. Signs of aggregation in a reconstituted peptide solution include visible particulates or cloudiness; a properly reconstituted solution should be clear.
Alpha-MSH (Alpha-Melanocyte-Stimulating Hormone)#: A 13-amino-acid peptide derived from pro-opiomelanocortin (POMC) that is the endogenous ligand at MC1R and activates multiple melanocortin receptor subtypes. Alpha-MSH is studied for its roles in pigmentation regulation, appetite suppression via MC4R in the hypothalamus, and anti-inflammatory signaling in animal models. Synthetic analogs of alpha-MSH with improved stability and potency, such as Melanotan II, were developed as research tools to probe melanocortin receptor pharmacology.
Amino Acid#: The fundamental building blocks of proteins and peptides, each consisting of an amino group, a carboxyl group, a hydrogen atom, and a side chain attached to a central carbon. Twenty standard amino acids combine in different sequences to form the enormous variety of naturally occurring peptides. The specific sequence and stereochemistry of amino acids determine a peptide's structure, stability, and biological activity in research systems.

B

Bacteriostatic Water#: Sterile water for injection containing 0.9% benzyl alcohol as a preservative, which inhibits microbial growth without killing organisms outright. It is the standard diluent used to reconstitute lyophilized research peptides because the preservative extends the usable life of the solution at refrigerator temperature compared to plain sterile water. Bacteriostatic water should not be confused with sterile saline or plain water, as the benzyl alcohol concentration is specifically calibrated to preserve multi-dose solutions.
Batch Number#: A unique identifier assigned by a manufacturer to a specific production run of a compound, enabling traceability from synthesis through third-party testing to the end user. A legitimate Certificate of Analysis will reference the exact batch number of the product it certifies, allowing researchers to confirm that the tested material corresponds to their specific vial. Without a matching batch number, a COA cannot verify the contents of any particular order.
Bioavailability#: The fraction of an administered compound that reaches systemic circulation in an active form, expressed as a percentage of the administered dose. For peptides, bioavailability varies widely by route of administration: intravenous delivery achieves near-complete bioavailability, while oral delivery is typically very low due to proteolytic degradation in the gastrointestinal tract. Subcutaneous administration generally provides intermediate bioavailability that varies by peptide molecular weight and structure.
BPC-157#: A synthetic 15-amino-acid peptide (sequence: GEPPPGKPADDAGLV) derived as a partial sequence of body protection compound, a protein found in human gastric juice. BPC-157 is studied in animal model research primarily in the context of tissue repair, angiogenesis, and gastrointestinal mucosal protection. It is supplied lyophilized, is temperature-sensitive after reconstitution, and is sold for laboratory research use only.

C

Certificate of Analysis (COA)#: A formal document from a testing laboratory that certifies the identity, purity, and potency of a specific batch of material. For research peptides, a COA from a qualified third-party laboratory should include HPLC-derived purity data with a chromatogram, mass spectrometry identity confirmation, the batch number, the testing date, and the name of the issuing laboratory. A generic or undated spec sheet that is reused across multiple production runs cannot substitute for a true batch-specific COA.
CJC-1295#: A synthetic peptide analog of growth hormone-releasing hormone (GHRH) that incorporates amino acid substitutions to resist proteolytic degradation and, in the DAC (Drug Affinity Complex) form, an additional modification that covalently binds to albumin in plasma to extend its half-life. CJC-1295 is studied in animal models as a tool to interrogate sustained GHRH signaling and its effects on pulsatile growth hormone secretion. It is for laboratory research use only.
Cold-Chain Shipping#: A temperature-controlled logistics process that keeps a product refrigerated or frozen from the point of packaging through delivery. Many research peptides are temperature-sensitive and can degrade if exposed to elevated temperatures during transit, making cold-chain packaging — insulated containers, gel packs or dry ice — a material quality variable. Vendors that ship temperature-sensitive peptides in standard envelopes without thermal protection risk delivering degraded material regardless of the initial purity.
Colmaric Analyticals#: A US-based contract analytical laboratory that provides third-party testing services including HPLC purity analysis and mass spectrometry identity confirmation for research compounds and peptides. Along with Janoshik Analytical and MZ Biolabs, it is one of the named laboratories whose COA documentation is generally recognized in the research peptide community as credible third-party verification. Certificates from named, independent labs are distinguishable from unnamed or in-house testing because their independence can be verified.
Concentration#: The amount of a solute (such as a reconstituted peptide) dissolved in a given volume of solvent, commonly expressed in micrograms per milliliter (mcg/mL) or milligrams per milliliter (mg/mL) for peptide research solutions. Concentration is the key output of the reconstitution calculation: dividing the total milligrams in a vial by the volume of bacteriostatic water added yields the stock concentration, from which per-unit volumes for insulin syringes are derived. Accurate concentration calculation is foundational to reproducible research protocols.

D

Disulfide Bond#: A covalent bond formed between the sulfur atoms of two cysteine residues within or between peptide chains, often critical to the three-dimensional conformation and stability of a peptide. Many bioactive peptides rely on disulfide bonds for their structural integrity; improper storage or reconstitution conditions can disrupt these bonds and alter activity in research systems. The presence or absence of correct disulfide bonding is sometimes confirmed by mass spectrometry analysis.

E

Endotoxin#: Lipopolysaccharide (LPS) components derived from the outer membrane of gram-negative bacteria, which can contaminate biologics and peptide preparations produced in certain fermentation or synthesis environments. Even at low concentrations, endotoxins can trigger strong inflammatory responses in cell-based and animal research systems, potentially confounding experimental results. Research-grade peptide vendors that test for endotoxin levels using the Limulus Amebocyte Lysate (LAL) assay provide an additional quality marker beyond purity alone.
Epithalon#: A synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland extract epithalamin, studied primarily in the context of telomerase activation, telomere length, and cellular aging in cell culture and rodent models. Epithalon is among the shorter peptides commonly researched, giving it distinctive stability properties compared to larger GHRH or GHRP analogs. It is sold in lyophilized form and is for laboratory research use only.
Excipient#: An inactive ingredient included in a formulation to aid manufacturing, stability, or delivery, rather than providing the active effect being studied. In lyophilized peptide preparations, common excipients include mannitol or trehalose (as lyoprotectants that help preserve peptide structure during freeze-drying) and acetic acid (to adjust pH). A COA or product specification should identify any excipients present so researchers can account for them in experimental design.

F

Freeze-Thaw Cycle#: A single complete episode of freezing a peptide solution and then thawing it back to liquid form. Repeated freeze-thaw cycles are a significant cause of peptide degradation and aggregation because mechanical stresses during ice crystal formation and remelting can damage molecular structure and promote intermolecular aggregation. Best practice in research protocols is to reconstitute only the volume needed for near-term use, or to aliquot reconstituted solutions into single-use portions before freezing to minimize the number of freeze-thaw cycles any given aliquot undergoes.

G

GH Axis#: The neuroendocrine signaling cascade that regulates the synthesis and secretion of growth hormone (GH), involving hypothalamic releasing and inhibiting hormones, pituitary GH cells, and downstream mediators such as IGF-1. Key regulatory inputs include growth hormone-releasing hormone (GHRH), which stimulates GH release, and somatostatin, which inhibits it. Many research peptides in the secretagogue class are studied because they interact with components of this axis in animal and cell-based models.
GHK-Cu#: A naturally occurring copper-binding tripeptide (glycyl-l-histidyl-l-lysine) found in human plasma, urine, and saliva, studied in research for its roles in wound healing, collagen synthesis stimulation, and antioxidant signaling in cell culture models. GHK-Cu chelates copper ions through its histidine and terminal amino groups; the copper appears to be important for some of its biological activities in model systems. It is supplied for laboratory research use only.
GHRH (Growth Hormone-Releasing Hormone)#: A 44-amino-acid hypothalamic peptide that binds to receptors on anterior pituitary somatotrophs and stimulates the synthesis and pulsatile secretion of growth hormone. Endogenous GHRH is released in a pulsatile pattern that interacts with somatostatin to produce the characteristic GH secretory rhythm observed in mammals. Several synthetic peptide analogs studied in research are designed to mimic or potentiate GHRH signaling at the pituitary receptor.
GHRP (Growth Hormone-Releasing Peptide)#: A family of synthetic peptides that stimulate growth hormone secretion through the ghrelin receptor (GHSR-1a), acting via a mechanism distinct from and synergistic with GHRH. Members of the GHRP family studied in research include GHRP-2, GHRP-6, and their derivatives; they differ in potency, selectivity, and appetite-stimulating side effects linked to ghrelin receptor activity. GHRPs are classified as growth hormone secretagogues because they cause GH release without being structurally related to GHRH.
GLP-1 (Glucagon-Like Peptide-1)#: An incretin hormone released from intestinal L-cells in response to nutrient ingestion, which potentiates glucose-dependent insulin secretion, inhibits glucagon release, and slows gastric emptying. GLP-1 and its pharmacologically stabilized analogs have been extensively studied in metabolic and pancreatic research, and the GLP-1 receptor is the molecular target of a major class of pharmacological agents. In research contexts, GLP-1 and its peptide agonists are studied as tools to interrogate energy homeostasis, insulin dynamics, and neurological signaling in model systems.

H

Half-Life#: The time required for the concentration of a compound in a biological system to decrease by one half, reflecting the combined effects of distribution, metabolism, and elimination. Peptides often have short half-lives in vivo because they are susceptible to proteolytic cleavage by circulating and tissue-bound enzymes; chemical modifications such as PEGylation or cyclization are sometimes used in research analogs to extend stability. Understanding a compound's half-life is essential for designing temporally accurate research protocols.
Hexarelin#: A synthetic hexapeptide growth hormone-releasing peptide and potent ghrelin receptor agonist, among the first synthetic GHRPs studied for its ability to stimulate pulsatile growth hormone secretion in animal research models. Hexarelin binds to both the ghrelin receptor and the CD36 scavenger receptor, and research has examined its activity in cardiac and adipose tissue models in addition to its pituitary effects. It is for laboratory research use only.
HPLC (High-Performance Liquid Chromatography)#: An analytical technique that separates components of a mixture by passing it under high pressure through a column packed with a stationary phase, detecting each component as it elutes and quantifying it relative to known standards. For research peptides, reverse-phase HPLC is the standard method for measuring purity; a purity value of ≥98% by HPLC area percent is generally considered the benchmark for research-grade material. The HPLC chromatogram — a graphical output showing peaks corresponding to each detected component — is the evidentiary document that supports a purity claim, and a legitimate COA should include it.

I

IGF-1 (Insulin-Like Growth Factor 1)#: A 70-amino-acid peptide hormone produced primarily in the liver in response to growth hormone stimulation, which mediates many of GH's anabolic and growth-promoting effects in peripheral tissues. IGF-1 binds to the IGF-1 receptor, a receptor tyrosine kinase expressed in most cell types, and activates intracellular signaling cascades involved in cell survival, proliferation, and metabolism. Research involving the GH axis often includes IGF-1 measurements as a downstream readout of GH secretory activity.
Insulin Syringe#: A small-volume syringe calibrated in insulin units (U-100 = 100 units/mL = 1 mL total), widely used in research settings for precise delivery of small volumes of reconstituted peptide solutions. The U-100 calibration means each unit mark on the syringe corresponds to 0.01 mL (10 µL), enabling measurement of volumes in the low-microliter range needed for research dosing. Reconstitution calculators for research peptides typically output volumes in "units" (U-100 syringe units) to match the instrument researchers are handling.
Ipamorelin#: A selective synthetic pentapeptide growth hormone secretagogue that acts as an agonist at the ghrelin receptor (GHS-R1a) to stimulate growth hormone release with greater selectivity — and less cortisol or appetite stimulation — than earlier GHRP compounds. In preclinical research, ipamorelin's selectivity for GH release has made it a useful tool for studying pituitary function without the confounding effects on the HPA axis seen with GHRP-6. It is for laboratory research use only.
Isobaric Interference#: A phenomenon in mass spectrometry where two or more compounds have the same or nearly identical nominal mass, potentially causing one to be mistaken for another in low-resolution analysis. For peptide identity confirmation, isobaric interference is one reason that high-resolution mass spectrometry or tandem MS/MS fragmentation is preferred over simple nominal-mass matching. A well-designed COA will note the method and resolution used so researchers can assess whether isobaric compounds could confound the identity result.

J

Janoshik Analytical#: A Czech Republic-based independent contract laboratory widely used by research peptide vendors to perform HPLC purity testing and mass spectrometry identity confirmation on peptide compounds. Janoshik is one of a small number of named third-party labs whose certificates are generally accepted as credible independent verification in the research peptide community. When evaluating a COA, confirming that the issuing laboratory is a named, verifiable independent entity — rather than an unnamed or in-house facility — is a baseline quality check.

L

Lyophilization#: A dehydration process — also called freeze-drying — in which a solution is first frozen and then subjected to vacuum, causing the ice to sublimate directly to water vapor without passing through a liquid phase. Lyophilization is the standard method for producing stable, long-shelf-life peptide products because it removes water while preserving the molecular structure of the peptide in a powder or cake form. Lyophilized peptides are reconstituted by adding a measured volume of an appropriate diluent (typically bacteriostatic water) before use.
Lyophilized#: Describes a compound or biological material that has been processed by lyophilization (freeze-drying) to remove water and produce a dry powder or cake. Research peptides are almost universally supplied in lyophilized form because the dry state greatly extends shelf life and thermal stability compared to aqueous solutions. A lyophilized peptide must be reconstituted — dissolved in an appropriate sterile diluent — before it can be used in solution-phase research protocols.
Lyoprotectant#: An excipient added to a peptide formulation before lyophilization to protect the compound's structure during freeze-drying by replacing the hydrogen bonds normally provided by water molecules. Common lyoprotectants include trehalose, mannitol, sucrose, and lactose; their presence preserves peptide conformation in the dry state and typically improves the reconstitution characteristics and long-term stability of the lyophilized product. A well-formulated lyophilized peptide with an appropriate lyoprotectant will reconstitute rapidly and completely in the recommended diluent volume.

M

Mass Spectrometry#: An analytical technique that ionizes chemical species and separates the resulting ions by their mass-to-charge ratio (m/z), producing a spectrum that can identify a compound by its characteristic molecular mass and fragmentation pattern. For peptide identity confirmation, mass spectrometry is used to verify that the peptide in a vial has the correct molecular weight corresponding to its claimed amino acid sequence, guarding against substitution with a cheaper or incorrect compound. High-resolution instruments and MS/MS fragmentation methods can identify peptides with greater specificity than low-resolution nominal-mass measurements alone.
Melanotan II#: A synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH), studied as a ligand at melanocortin receptors (MC1R, MC3R, MC4R) in animal models. Research on Melanotan II has focused on melanocortin receptor pharmacology, pigmentation biology, and energy homeostasis in preclinical systems. It is a research compound for laboratory use only and is not approved for any human therapeutic application.
Molecular Weight#: The sum of the atomic masses of all atoms in a molecule, expressed in daltons (Da) or unified atomic mass units (u). For peptides, molecular weight is a key identity parameter: the theoretical molecular weight calculated from an amino acid sequence can be compared against the measured mass from a mass spectrometry analysis to confirm that the correct compound is present. Larger molecular weights generally correlate with longer peptide sequences, which can affect biodistribution, receptor binding, and stability characteristics relevant to research design.
MZ Biolabs#: A US-based contract analytical laboratory offering HPLC purity analysis, mass spectrometry, and related testing services for research compounds including peptides. MZ Biolabs is one of a small set of named, independent US labs whose analytical certificates are recognized in the research peptide sourcing community as credible third-party documentation. Selecting vendors whose COAs originate from verifiable, named laboratories such as MZ Biolabs provides a meaningful layer of quality assurance compared to unnamed or in-house testing.

O

Oxytocin#: A cyclic nonapeptide neuropeptide synthesized in hypothalamic nuclei and released from the posterior pituitary, with well-characterized roles in uterine contraction, lactation, and social bonding behaviors. In research contexts, oxytocin is studied as a neuromodulator affecting trust, pair bonding, anxiety, and stress responses in animal models and through receptor pharmacology. It is a naturally occurring peptide and is also synthesized for research use.

P

Peptide#: A molecule consisting of two or more amino acids linked by peptide bonds, generally distinguished from proteins by shorter chain length (typically fewer than 50 amino acids, though the boundary is not strict). Peptides span an enormous range of biological functions — hormones, neurotransmitters, signaling molecules, antimicrobial agents — and are the subject of active research in fields from endocrinology to tissue biology to immunology. In the research compound context, the term "peptide" most commonly refers to short synthetic amino acid sequences produced for laboratory investigation.
Peptide Bond#: A covalent amide bond formed between the carboxyl group of one amino acid and the amino group of the next, with the release of a water molecule, creating the backbone linkage that chains amino acids into a peptide. The peptide bond has partial double-bond character due to resonance, which constrains the bond angle and contributes to the secondary structure preferences (alpha-helices, beta-sheets) of peptide chains. Enzymatic hydrolysis of peptide bonds by proteases is the primary mechanism by which the body degrades circulating peptides, limiting their systemic half-life.
Peptide Purity#: A measure of what fraction of a peptide sample consists of the intended target compound versus impurities such as truncated sequences, deletion analogs, oxidized species, or synthesis byproducts. HPLC purity is expressed as a percentage of the total peak area in a chromatogram attributable to the target peptide peak, and ≥98% is the widely cited benchmark for research-grade material. Lower purity values indicate the presence of undefined impurities that may interfere with experimental results, making purity a primary quality criterion when sourcing peptides for research.
Peptide YY (PYY)#: A 36-amino-acid peptide released from intestinal L-cells in proportion to caloric intake, which acts as a satiety signal by binding to neuropeptide Y receptors in the hypothalamus and gut to inhibit food intake. PYY is studied in metabolic research as a gut-brain signaling molecule and is a member of the pancreatic polypeptide family, sharing structural features with neuropeptide Y and pancreatic polypeptide. Research involving GLP-1 signaling often includes PYY as a co-secreted L-cell product.
pH#: A logarithmic scale representing the concentration of hydrogen ions in a solution, ranging from 0 (highly acidic) to 14 (highly alkaline), with 7 as neutral. Peptide stability, solubility, and conformation are sensitive to pH; many peptides are optimally soluble and stable within a narrow pH range near physiological pH (approximately 7.4). Reconstitution with bacteriostatic water (typically pH ~5–7) generally keeps most peptides in a stable range, but highly charged or amphipathic peptides may require specific pH adjustment for complete dissolution.
Pharmacokinetics#: The study of how a compound moves through a biological system over time, encompassing absorption, distribution, metabolism, and elimination — collectively abbreviated ADME. For peptide research, pharmacokinetics describes parameters such as peak plasma concentration (Cmax), time to peak (Tmax), half-life, volume of distribution, and clearance rate. Understanding pharmacokinetic profiles is essential for designing dosing intervals in animal model research and for interpreting time-course experimental data.
Protease#: An enzyme that catalyzes the hydrolysis of peptide bonds, breaking down proteins and peptides into smaller fragments or individual amino acids. Proteases are ubiquitous in biological systems — present in blood, tissues, the gastrointestinal tract, and intracellular compartments — and are the primary reason most natural peptides have short half-lives in vivo. Research peptide analogs may incorporate non-natural amino acids, d-amino acid substitutions, or cyclization to reduce protease susceptibility and extend activity in model systems.
Purity#: In the context of research peptides, purity refers to the proportion of the sample that consists of the target compound, with all other substances classified as impurities. HPLC area percent purity is the standard measurement, and a threshold of ≥98% is commonly required for research-grade classification. High purity is critical because uncharacterized impurities — synthesis byproducts, deletion peptides, or degradation products — can confound experimental outcomes and make results difficult to reproduce or interpret.

R

Reconstitution#: The process of dissolving a lyophilized (freeze-dried) peptide in a precise volume of an appropriate sterile liquid — typically bacteriostatic water — to produce a solution of a known concentration for research use. Proper reconstitution involves adding the diluent slowly to avoid excessive agitation (which can cause aggregation), allowing complete dissolution, and storing the resulting solution under conditions specified by the research protocol. Accurate reconstitution is essential because errors in the diluent volume directly translate to errors in concentration and thus in any volume-based protocol.
Reverse-Phase HPLC#: The most common HPLC configuration for peptide analysis, in which the stationary phase is nonpolar (typically C18-functionalized silica) and the mobile phase is a polar aqueous-organic solvent gradient. In reverse-phase HPLC, more hydrophobic compounds are retained longer on the column and elute later, providing separation of peptides by hydrophobicity as well as molecular size. The resulting chromatogram shows peaks for each detected component, with peak area used to calculate the purity of the target peptide relative to all detected impurities.

S

Secretagogue#: Any agent that stimulates the secretion of another substance from a cell or gland. In peptide research, the term is most commonly applied to compounds that stimulate the secretion of growth hormone from pituitary somatotrophs, including GHRHs and GHRPs. Growth hormone secretagogues are studied because they can activate endogenous GH secretion through different receptor pathways, making them tools for interrogating pituitary function and GH axis dynamics in research models.
Sequence Verification#: Analytical confirmation that the amino acid sequence of a synthesized peptide matches its intended design, typically performed by tandem mass spectrometry (MS/MS) which fragments the peptide and identifies amino acids from the resulting fragment ion series. Sequence verification goes beyond simple molecular weight confirmation because two different peptide sequences can occasionally have nearly identical masses (isobaric sequences), and only fragmentation analysis can distinguish them. High-quality research peptide vendors include sequence verification data in their COAs or offer it upon request.
Solid-Phase Peptide Synthesis (SPPS)#: The dominant method for manufacturing synthetic peptides, in which the peptide chain is assembled step-by-step on an insoluble polymer support (resin), with each amino acid added sequentially from C-terminus to N-terminus. At the end of synthesis, the completed peptide is cleaved from the resin and deprotected, then purified by HPLC to remove synthesis byproducts such as deletion sequences, truncated peptides, and protecting-group remnants. The purity of the final SPPS product — and thus the quality of the research compound — depends critically on the efficiency of each coupling step and the thoroughness of the purification process.
Somatostatin#: A cyclic 14-amino-acid (or 28-amino-acid) hypothalamic neuropeptide that inhibits the release of growth hormone, thyroid-stimulating hormone, and several gastrointestinal hormones including glucagon and insulin. Somatostatin acts as the primary off-switch in the GH axis, opposing the stimulatory effect of GHRH in a pulsatile interplay that determines the amplitude and frequency of GH secretory pulses. Research on GH axis modulation often involves understanding or manipulating the balance between GHRH and somatostatin activity.
Sterility#: The complete absence of viable microorganisms — bacteria, fungi, mycoplasma, and viruses — in a preparation or on a surface. For research peptide solutions intended for injection into animal subjects, sterility is a critical quality attribute because microbial contamination can introduce confounding variables, cause infection, or invalidate experimental results. Sterility can be achieved by sterile filtration through a 0.2 µm membrane or by aseptic manufacturing practices; a COA may include sterility testing data as an additional quality indicator.
Storage Conditions#: The environmental parameters — principally temperature, humidity, and light exposure — specified for maintaining a compound's integrity and potency over time. Lyophilized peptides are generally stable at -20°C for extended periods and at 2–8°C for months, but many degrade significantly at room temperature or with repeated freeze-thaw cycles. Reconstituted peptide solutions are considerably less stable than the lyophilized form and should be stored under refrigeration, used within the period specified by the research protocol, and not exposed to direct light.
Subcutaneous Administration#: Delivery of a compound into the subcutaneous tissue layer just below the skin but above the muscle, commonly via a short, fine-gauge needle such as those on insulin syringes. The subcutaneous compartment provides a depot from which compounds are absorbed into the bloodstream relatively slowly compared to intravenous injection, producing a more gradual concentration-time profile. In peptide research using animal models, subcutaneous administration is frequently chosen because it is well-tolerated, reproducible, and does not require anesthesia or surgical access.

T

TB-500#: A synthetic peptide analog corresponding to a conserved actin-binding region (amino acids 17–23) of thymosin beta-4, a naturally occurring 43-amino-acid protein involved in actin sequestration and cell motility regulation. TB-500 is studied in research contexts related to cytoskeletal dynamics, tissue remodeling, and wound healing in cell and animal models. It is supplied lyophilized and is for laboratory research use only.
Third-Party Testing#: Independent analytical testing performed by a laboratory with no financial interest in the manufacturer or vendor of the product being tested. Third-party testing is the cornerstone of research peptide quality verification because it removes the conflict of interest inherent in self-reported or in-house testing. A COA is only as credible as the independence of the laboratory that issued it; confirmation that the testing lab is a named, verifiable, commercially independent entity is a basic step in evaluating any research compound supplier.

U

UV Absorbance Detection#: The most common detection method in HPLC analysis of peptides, in which compounds are identified as they elute from the column by their absorbance of ultraviolet light at a fixed wavelength — typically 214 nm for peptide bonds or 280 nm for aromatic residues. The area under each UV absorbance peak is proportional to the amount of material present, allowing calculation of the percentage of the total signal attributable to the target peptide. Purity values on peptide COAs are generally reported as UV area percent at 214 nm unless otherwise specified.

V

Vasopressin#: A cyclic nonapeptide neuropeptide (also called antidiuretic hormone, ADH) produced in the hypothalamus that regulates water reabsorption in the kidney and vasoconstriction at high concentrations. Vasopressin and oxytocin are structurally related, differing by only two amino acids, and share overlapping receptor binding; their evolutionary divergence is a classic example of how small sequence changes produce distinct physiological functions. Both peptides are studied as tools in receptor pharmacology and neuroendocrine research.
Vial Size#: The total mass of lyophilized peptide contained in a sealed research vial, typically expressed in milligrams (e.g., 5 mg, 10 mg). Vial size is the starting variable in all reconstitution calculations: dividing the vial's mass by the volume of diluent added gives the stock solution concentration. Common research peptide vial sizes range from 2 mg to 10 mg depending on the compound and vendor; larger vials are often more economical per milligram but require ensuring that the full quantity can be used before the reconstituted solution degrades.

Definitions are written for research context and are for informational purposes only. Nothing in this glossary constitutes medical advice, dosing guidance, or a recommendation to use any compound in humans. All peptides and compounds referenced are for laboratory research use only.

2026 Evaluation

9.6/10

Top-Ranked 2026 Supplier

The highest-rated source in our 2026 HPLC evaluation

Before sourcing any research peptide, verify the COA: batch-specific, third-party HPLC chromatogram, ≥98% purity, named lab. ROEHN Research scored 9.6/10 in our 38-sample blinded evaluation — the only supplier where every tested vial met its label claim. Readers save 15% with code FREE15.

View ROEHN Research

Save 15% with code FREE15

Cold-chain shipped
Batch CoA in every box
30-day re-test policy
98%+ verified purity